[Frontiers in Bioscience 3, d44-58, January 1, 1998]

	[Frontiers in Bioscience 3, d44-58, January 1, 1998] Reprints PubMed CAVEAT LECTOR
	CHEMOKINE RECEPTORS AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION Paul D. Bieniasz and Bryan R. Cullen Department of Genetics and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710 Received 12/15/97 Accepted 12/19/97 8. REFERENCES 1. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A. and Axel, R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348 (1986). 2. Planelles, V., Li, Q.-X. and Chen, I.S.Y. The biological and molecular basis for cell tropism in HIV. In Cullen, B.R. (ed.), Human Retroviruses, Oxford University Press, Oxford, UK, 17-48 (1993). 3. James, W., Weiss, R.A. and Simon, J.H. The receptor for HIV: Dissection of CD4 and studies on putative accessory factors. Curr. Top. Microbiol. Immunol 205, 137-158 (1996). 4. Clapham, P. R., Blanc, D. and Weiss, R. A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181, 703-715 (1991). 5. Dragic, T., Charneau, P., Clavel, F. and Alizon, M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol. 66, 4794-4802 (1992). 6. Gartner, S., Markovits, P., Markovitz, D., Kaplan, M., Gallo, R. and Popovic, M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219 (1986). 7. Cheng-Mayer,C., Seto, D., Tateno, M. and Levy, J.A. Biological features of HIV that correlate with virulence in the host. Science 240, 80-82 (1988). 8. Fenyo, E., Morfeldt-Mason,L., Chiodi, F., Lind, B., VonGegerfelt, A., Albert, J. and Asjo, B. Distinctive replicative and cytopathic characteristics of human immunodeficiency virus isolates. J.Virol. 62, 4414-4419 (1988). 9. Schuitemaker, H., Kootstra, N., de Goede, R., de Wolf, F., Miedema, F. and Tersmette, M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65, 356-363 (1991). 10. Collman, R., Balliet J.W., Gregory, S.A., Friedman, H., Kolson, D.L., Nathanson, N. and Srinivasan, A. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517-7521 (1992). 11. Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P. W., Weiss, R. A. and Clapham, P. R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355-8360 (1996). 12. Zhang, L., Y. Huang, T. He, Y. Cao, Y. and Ho, D.D. HIV-1 subtype and second-receptor use. Nature 383, 768 (1996). 13. Hwang, S. S., Boyle, T. J., Lyerly, H. K. and Cullen, B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74 (1991). 14. Shioda, T., Levy, J.A. and Cheng-Mayer, C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349, 167-169 (1991). 15. O’Brien, W.A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., Idler, K., Zack, J.A. and Chen, I.S.Y. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348, 69-73 (1990) . 16. Westervelt, P., Gendelman, H.E. and Ratner, L. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88, 3097-3101 (1991). 17. Boyd, M.T., Simpson, G.R., Cann, A.J., Johnson, M.A. and Weiss, R.A. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67, 3649-3652 (1993). 18. Kim, F. M., Kolson, D.L., Balliet, J. W., Srinivasan, A. and Collman, R. G. V3 independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J. Virol. 69, 1755-1761 (1995). 19. Koito, A., Harrowe, E., Levy, J. A. and Cheng-mayer, C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J.Virol. 68, 2253-2259 (1994). 20. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996) 21. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M. and Moser, B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835 (1996). 22. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996). 23. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8⁺ T Cells. Science 270, 1811-1815 (1995). 24. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. and Berger, E. A. CC CKR5: A RANTES, MIP-1 alpa, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996). 25. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996). 26. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996). 27. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. and Doms, R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996). 28. Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. and Paxton, W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673 (1996). 29. Björndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., Albert, J., Scarlatti, G., Littman, D. R. and Fenyö, E. M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478-7487 (1997). 30. Marcon, L., Choe, H., Martin, K. A., Farzan, M., Ponath, P. D., Wu, L., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71, 2522-2527 (1997). 31. Chen, Z., Zhou, P., Ho, D. D., Landau, N. R. and Marx, P. A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71, 2705-2714 (1997). 32. Kirchhoff, F., Pöhlmann, S., Hamacher, M., Means, R. E., Kraus, T., Überla, K. and Di Marzio, P. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 71, 6509-6516 (1997). 33. Deng, H., Unutmaz, D., KewalRamani, V. N. and Littman, D. R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300 (1997). 34. Alkhatib, G., Liao, F., Berger, E. A., Farber, J. M. and Peden, K. C. W. A new SIV coreceptor, STRL33. Nature 388, 238 (1997) 35. Farzan, M., Choe, H., Martin, K., Marcon, L., Hofman, W., Karlsson, G., Sun, Y., Barret, P., Marchand, N., Sullivan, N., Gerard, N., Gerard, G., and Sodroski, J. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186, 405-411 (1997). 36. Liao, F., Alkhatib, G., Peden, K. W. C., Sharma, G., Berger, E. A. and Farber, J. M. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015-2023 (1997). 37. Sol, N., Ferchal, F., Braun, J., Pleskoff, O., Treboute, C., Ansart, I. and Alizon, M. Usage of the coreceptors CCR-5 CCR-3 and CXCR-4 by primary and cell-line adapted human immunodeficiency virus type 2. J. Virol. 71, 8237-8244 (1997). 38. Paxton, W. A., Martin, S. R., Tse, D., O'Brien, T. R., Skurnick, J., Vandevanter, N. L., Padian, N., Braun, J. F., Kotler, D. P., Wolinsky, S. M. and Koup, R.A. relative resistance to HIV infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposures. Nature Med. 2, 412-417 (1996). 39. Connor, R. I., Paxton, W. A., Sheridan, K. E. and Koup, R. A. Macrophages and CD4+ T lymphocytes from two multiply exposed uninfected individuals resist infection with primary non-syncytium inducing isolates of human immunodeficiency virus type 1. J. Virol. 70, 8757-8764 (1996). 40. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. M., Stuhlmann, H., Koup, R. A. and Landau, N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996). 41. Dean, M., Carrington, M. Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S.J. Genetic Restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996). 42. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996). 43. Biti, R., French, R., Young, J., Bennetts, B. and Stewart, G. HIV-1 infection in an individual homozygous for the CCR-5 deletion mutant. Nature Med. 3, 252-253 (1997) 44. O'Brien, T. R., Winkler, C., Dean, M., Nelson, J. A. E. Carrington, M., Michael, N., L., and White G. C. HIV-1 infection in a man homozygous for CCR-5 delta32. Lancet 349, 1219 (1997). 45. Theodorou, I., Meyer, l., magierowska, M., Katlana, C., and Rouzioux, C. HIV infection in an individual homozygous for CCR-5 delta32. Lancet 349, 1219-1220 (1997). 46. Balotta, C., Bagnarelli, P., Violin, M., Ridolfo, A. L., Zho, D., Berlusconi, A., Corvasce, S., Corbellino, M., Clementi, M., Clerici, M., Moroni, M. and Galli, M. Homozygous delta32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11, 67-71 (1997). 47. Meyer, L., Magierowska, M., Hubert, J.-B., Rouzioux, C., Deveau, C., Sanson, F., Debre, P., Delfraissy, J.-F., Theodorou, I. and the SEROCO Study Group. Early protective effect of CCR-5 delta32 heterozygosity on HIV-1 disease progression: Relationship with viral load. AIDS 11, 73-78 (1997). 48. Sallusto, F., Mackay, C. R. and Lanzavecchia, A. Selective expression of of the Eotaxin receptor CCR-3 by human T helper 2 cells. Science 277, 2005-2007 (1997). 49. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C. R., Sodroski, J. and Gabuzda, D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645-649 (1997). 50. Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O’Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K. and Hilgartner, M. W. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965 (1997). 51. Wu, B. L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A. and Mackay, C. R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J. Exp. Med. 185, 1681-1691 (1997). 52. Lapham, C.K., Ouyang, J., Chandrasekhar, B., Nguyen, N.Y., Dimitrov, D.S. and Golding, H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274, 602-605 (1996). 53. Hesselgesser, J., Halks-Miller, M., DelVecchio, V., Peiper, S. C., Hoxie, J., Kolson, D. L., Taub, D. and Horuk, R. CD4 independent interaction between HIV-1 gp120 and CXCR-4: Functional chemokine receptors are expressed in human neurons. Curr. Biol. 7, 112-121 (1997). 54. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J. and Moore, J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187 (1996). 55. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183 (1996). 56. Hill, C. M., Deng, H., Unutmaz, D., Kewalramani, V.N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S. and Littman, D. R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71, 6296-6304 (1997). 57. Clapham, P. R., McKnight, A. and Weiss, R. A. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4. J. Virol. 66, 3531-3537 (1992). 58. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., Wells, T. N. C., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau, N. R. and Hoxie, J. A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996). 59. Reeves, J. D., McKnight, A., Potempa., S. Simmons, G., Gray, P. W., Power, C. A., Wells, T., Weiss, R. A. and Talbot, S. J. CD4 independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3 and V28 for entry. Virology 231, 130-134 (1997). 60. Atchison, R.E., Gosling, J., Monteclaro, F.S., Franci, C., Digilio, L., Charo, I.F. and Goldsmith, M.A. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines. Science 274, 1924-1926 (1996). 61. Bieniasz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S. G., Caron, M. G. and Cullen, B. R. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J. 16, 2599-2609 (1997). 62. Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A. and Clapham, P. R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71, 5003-5011 (1997). 63. Kuhmann, S. E., Platt, E. J., Kozak, S. L. and Kabat, D. Polymorphisms in the CCR5 genes of african green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J. Virol. 71, 8642-8656 (1997). 64. Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., Doms, R. W. and Parmentier, M. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87, 437-446 (1996). 65. Lu, Z.-H., Berson, J. F., Chen, Y.-H., Turner, J. D., Zhang, T.-Y., Sharron, M., Jenks, M. H., Wang, Z.-X., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C. and Doms, R. W. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94, 6426-6431 (1997). 66. Doranz, B. J., Lu, Z.-H., Rucker, J., Zhang, T.-Y., Sharron, M., Cen, Y.-H., Wang, Z.-X., Guo, H.-H., Du, J.-G., Accavitti, M. A., Doms, R. W. and Peiper, S. C. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71, 6305-6314 (1997). 67. Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z.-H., Clements, J. E., Murphey-Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 94, 4005-4010 (1997). 68. Ross, T., Bieniasz, P. D. and Cullen, B. R. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage tropic HIV-1. J Virol In Press. 69. Heesen, M., Berman, M. A., Benson, J. D., Gerard, C. and Dorf, M. E. Cloning of the mouse fusin gene, homologue to a human HIV-1 co-factor. J. Immunol. 157, 5455-5460 (1996). 70. Nagasawa, T., Nakajima, T., Tachibana, K., Iizasa, H., Bleul, C. C., Yoshie, O., Matsushima, K., Yoshida, N., Springer, T. A. and Kishimoto, T. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA 93, 14726-14729 (1996). 71. Bieniasz, P. D., Fridell, R. A., Anthony, K. and Cullen, B. R. Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1. J. Virol. 71, 7097-7100 (1997). 72. Tachibana, K., Nakajima, T., Sato, A., Igarashi, K., Shida, H., Iizasa, H., Yoshida, N., Yoshie, O., Kishimoto, T. and Nagasawa, T. CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J. Exp. Med. 185, 1865-1870 (1997). 73. Pleskoff, O., N. Sol, B. Labrosse, and M. Alizon. Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (Fusin). J. Virol. 71 3259-3262 (1997). 74. Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. and Clapham, P. R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71, 6407-6415 (1997). 75. Ashorn, P. A., Berger, E A., and Moss, B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64, 2149-2156 (1990). 76. Kozak, S. L., Platt, E. J., Madani, N., Ferro, F. E., Jr., Peden, K. and Kabat, D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71, 873-882 (1997). 77. Simmons, G., McKnight, A., Takeuchi, Y., Hoshino, H. and Clapham, P. R. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: A V3 loop-determined restriction. Virology 209, 696-700 (1995). 78. Cheng-Mayer, C., Liu, R., Landau, N. R. and Stamatatos, L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71, 1657-1661 (1997). 79. Brelot, A., Heveker, N., Pleskoff, O., Sol, N. and Alizon, M. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71, 4744-4751 (1997). 80. Potempa, S., Picard, L., Reeves, J. D., Wilkinson, D., Weiss, R. A. and Talbot, S. J. CD4-independent infectin by human immunodeficiency virus type 2 strain ROD/B: The role of the N-terminal domain of CXCR-4 in fusion and entry. J. Virol. 71, 4419-4424 (1997). 81. Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B. and Goldsmith, M. A. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71, 7136-7139 (1997). 82. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. Bron, R., Klasse, P. J., Wilkinson, D., Clapham, P. R., Pelchen-Matthews, A., Power, C., Wells, T. N. C., Kim, J., Peiper, S. C., Hoxie, J. A. and Marsh, M. J. Virol. 71, 8405-8415 (1997). 83. Arenzanaseisdos, F., Virelizier, J. L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B. and Baggiolini, M. HIV blocked by a chemokine antagonist. Nature 383, 400 (1996). 84. Simmons, G., Clapham, P.R., Picard, L., Offord, R.E., Rosenkilde, M. M., Schwartz, T.W., Buser, R., Wells, T. N. C. and Proudfoot, W. E. I. Potent inhibition of HIV infectivity in macrophages and lymphocytes by a novel CCR-5 antagonist. Science 276, 276-279 (1997). 85. Kledal, T. N., Rosenkilde, M. M., Coulin, f., Simmons, G., Johnsen, A. H., Alouani, S., Power, C. A., Lutichau, H. R., Gerstoft, J., Clapham, P. R., Clark-lewis, I., Wells, T. N. C. and Schwartz, T. W. A broad spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated hepesvirus. Science 277, 1656-1659 (1997). 86. Boschoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., Moore, P. S., Chang, Y. And Weiss, R. A. Angiogenic and HIV-inhibitory functions of KSHV encoded chemokines. Science 278, 290-294 (1997). 87. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H. and Kishimoto, T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638 (1996). 88. Schols, D., Struyf, S., Van Damme, J. Esté, J.A., Henson, G. and De Clercq. E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388 (1997). 89. Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N. and Nagasawa,. T. A small molecule CXCR4 inhibitor that blocks T cell- line tropic HIV-1 infection. J. Exp. Med. 186, 1389-1393 (1997). 90. Doranz, B.J., Grovit-Ferbasi, K., Sharron, M.P., Mao, S.H., Goetz, M.B., Daar, E.S., Doms, R.W., and O'Brien, W. A. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395-1400 (1997). 91. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. and Landau, N. R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185, 621-628 (1997). 92. Moore, J. P. and Nara, P. L. The role of the V3 loop of gp120 in HIV infection. AIDS 5 Suppl 2, S21-S33 (1991). 93. Connor, R.I., Mohri, H., Cao, Y. and Ho, D.D. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol, 67, 1772-1777 (1993) 94. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A. and Mackay, C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930 (1997). 95. Malykh, A., Reitz, M. S., Louie, A., Hall, L. and Lori, F., Multiple determiants for growth of human immunodeficiency virus in monocyte-macrophages. Virology 206, 646-650 (1994). 96. Reimann, K. A., Li, J. T., Voss, G., Lekutis, C., Tenner-Racz, K., Racz, P., Lin, W., Montefiori, D. C., Lee-Parritz, D. E., Lu, Y., Collman, R. G., Sodroski, J. and Letvin, N. L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70, 3198-3206 (1996). 97. McKnight, A., Weiss, R.A., Chotton, C., Takeuchi, Y., Hoshino, H. and Clapham, P.R. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69, 3167-3170 (1995). 98. Moore, J. P., Cao, Y. , Qing, L. , Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R. and Ho, D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol. 69, 101-109 (1995). 99. Moore, J., Jameson, B., Weiss, R. and Sattentau, Q. In Viral fusion mechanisms. Ed: J. Bentz Ed. CRC Press, Boca Raton, FL 233-289 (1993). 100. Ferguson, S. S. G., Zhang, J., Barak, L. S. and Caron, M. G. G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration. Biochem Soc. Trans. 24, 953-959 (1996). 101. Gosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C.-L., Goldsmith, M. A. and Charo, I. F. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transd uction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066 (1997). 102. Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J. and Gerard, C. HIV-1 entry and macrophage inflammatory protein-1 beta-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272, 6854-6857 (1997). 103. Aramori, I., Zhang, J., Ferguson, S. S. G., Bieniasz, P. D., Cullen, B. R. and Caron, M. G. Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signalling and internalization are dissociable from its role as an HIV-1 coreceptor. EMBO J. 16, 4606-4616 (1997).

[Frontiers in Bioscience 3, d44-58, January 1, 1998]
Reprints
PubMed
CAVEAT LECTOR

CHEMOKINE RECEPTORS AND HUMAN IMMUNODEFICIENCY VIRUS INFECTION

Paul D. Bieniasz and Bryan R. Cullen

Department of Genetics and Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710

Received 12/15/97 Accepted 12/19/97

8. REFERENCES

1. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A. and Axel, R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348 (1986).

2. Planelles, V., Li, Q.-X. and Chen, I.S.Y. The biological and molecular basis for cell tropism in HIV. In Cullen, B.R. (ed.), Human Retroviruses, Oxford University Press, Oxford, UK, 17-48 (1993).

3. James, W., Weiss, R.A. and Simon, J.H. The receptor for HIV: Dissection of CD4 and studies on putative accessory factors. Curr. Top. Microbiol. Immunol 205, 137-158 (1996).

4. Clapham, P. R., Blanc, D. and Weiss, R. A. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181, 703-715 (1991).

5. Dragic, T., Charneau, P., Clavel, F. and Alizon, M. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol. 66, 4794-4802 (1992).

6. Gartner, S., Markovits, P., Markovitz, D., Kaplan, M., Gallo, R. and Popovic, M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219 (1986).

7. Cheng-Mayer,C., Seto, D., Tateno, M. and Levy, J.A. Biological features of HIV that correlate with virulence in the host. Science 240, 80-82 (1988).

8. Fenyo, E., Morfeldt-Mason,L., Chiodi, F., Lind, B., VonGegerfelt, A., Albert, J. and Asjo, B. Distinctive replicative and cytopathic characteristics of human immunodeficiency virus isolates. J.Virol. 62, 4414-4419 (1988).

9. Schuitemaker, H., Kootstra, N., de Goede, R., de Wolf, F., Miedema, F. and Tersmette, M. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable at all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65, 356-363 (1991).

10. Collman, R., Balliet J.W., Gregory, S.A., Friedman, H., Kolson, D.L., Nathanson, N. and Srinivasan, A. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517-7521 (1992).

11. Simmons, G., Wilkinson, D., Reeves, J. D., Dittmar, M. T., Beddows, S., Weber, J., Carnegie, G., Desselberger, U., Gray, P. W., Weiss, R. A. and Clapham, P. R. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355-8360 (1996).

12. Zhang, L., Y. Huang, T. He, Y. Cao, Y. and Ho, D.D. HIV-1 subtype and second-receptor use. Nature 383, 768 (1996).

13. Hwang, S. S., Boyle, T. J., Lyerly, H. K. and Cullen, B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74 (1991).

14. Shioda, T., Levy, J.A. and Cheng-Mayer, C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349, 167-169 (1991).

15. O’Brien, W.A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., Idler, K., Zack, J.A. and Chen, I.S.Y. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348, 69-73 (1990) .

16. Westervelt, P., Gendelman, H.E. and Ratner, L. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88, 3097-3101 (1991).

17. Boyd, M.T., Simpson, G.R., Cann, A.J., Johnson, M.A. and Weiss, R.A. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. J. Virol. 67, 3649-3652 (1993).

18. Kim, F. M., Kolson, D.L., Balliet, J. W., Srinivasan, A. and Collman, R. G. V3 independent determinants of macrophage tropism in a primary human immunodeficiency virus type 1 isolate. J. Virol. 69, 1755-1761 (1995).

19. Koito, A., Harrowe, E., Levy, J. A. and Cheng-mayer, C. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J.Virol. 68, 2253-2259 (1994).

20. Feng, Y., Broder, C. C., Kennedy, P. E. and Berger, E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877 (1996)

21. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M. and Moser, B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835 (1996).

22. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833 (1996).

23. Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C. and Lusso, P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8⁺ T Cells. Science 270, 1811-1815 (1995).

24. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. and Berger, E. A. CC CKR5: A RANTES, MIP-1 alpa, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).

25. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).

26. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. and Landau, N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666 (1996).

27. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. and Doms, R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).

28. Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. and Paxton, W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673 (1996).

29. Björndal, A., Deng, H., Jansson, M., Fiore, J. R., Colognesi, C., Karlsson, A., Albert, J., Scarlatti, G., Littman, D. R. and Fenyö, E. M. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71, 7478-7487 (1997).

30. Marcon, L., Choe, H., Martin, K. A., Farzan, M., Ponath, P. D., Wu, L., Newman, W., Gerard, N., Gerard, C. and Sodroski, J. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J. Virol. 71, 2522-2527 (1997).

31. Chen, Z., Zhou, P., Ho, D. D., Landau, N. R. and Marx, P. A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71, 2705-2714 (1997).

32. Kirchhoff, F., Pöhlmann, S., Hamacher, M., Means, R. E., Kraus, T., Überla, K. and Di Marzio, P. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J. Virol. 71, 6509-6516 (1997).

33. Deng, H., Unutmaz, D., KewalRamani, V. N. and Littman, D. R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300 (1997).

34. Alkhatib, G., Liao, F., Berger, E. A., Farber, J. M. and Peden, K. C. W. A new SIV coreceptor, STRL33. Nature 388, 238 (1997)

35. Farzan, M., Choe, H., Martin, K., Marcon, L., Hofman, W., Karlsson, G., Sun, Y., Barret, P., Marchand, N., Sullivan, N., Gerard, N., Gerard, G., and Sodroski, J. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J. Exp. Med. 186, 405-411 (1997).

36. Liao, F., Alkhatib, G., Peden, K. W. C., Sharma, G., Berger, E. A. and Farber, J. M. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185, 2015-2023 (1997).

37. Sol, N., Ferchal, F., Braun, J., Pleskoff, O., Treboute, C., Ansart, I. and Alizon, M. Usage of the coreceptors CCR-5 CCR-3 and CXCR-4 by primary and cell-line adapted human immunodeficiency virus type 2. J. Virol. 71, 8237-8244 (1997).

38. Paxton, W. A., Martin, S. R., Tse, D., O'Brien, T. R., Skurnick, J., Vandevanter, N. L., Padian, N., Braun, J. F., Kotler, D. P., Wolinsky, S. M. and Koup, R.A. relative resistance to HIV infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposures. Nature Med. 2, 412-417 (1996).

39. Connor, R. I., Paxton, W. A., Sheridan, K. E. and Koup, R. A. Macrophages and CD4+ T lymphocytes from two multiply exposed uninfected individuals resist infection with primary non-syncytium inducing isolates of human immunodeficiency virus type 1. J. Virol. 70, 8757-8764 (1996).

40. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. M., Stuhlmann, H., Koup, R. A. and Landau, N. R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).

41. Dean, M., Carrington, M. Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R. and O'Brien, S.J. Genetic Restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996).

42. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. and Parmentier, M. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).

43. Biti, R., French, R., Young, J., Bennetts, B. and Stewart, G. HIV-1 infection in an individual homozygous for the CCR-5 deletion mutant. Nature Med. 3, 252-253 (1997)

44. O'Brien, T. R., Winkler, C., Dean, M., Nelson, J. A. E. Carrington, M., Michael, N., L., and White G. C. HIV-1 infection in a man homozygous for CCR-5 delta32. Lancet 349, 1219 (1997).

45. Theodorou, I., Meyer, l., magierowska, M., Katlana, C., and Rouzioux, C. HIV infection in an individual homozygous for CCR-5 delta32. Lancet 349, 1219-1220 (1997).

46. Balotta, C., Bagnarelli, P., Violin, M., Ridolfo, A. L., Zho, D., Berlusconi, A., Corvasce, S., Corbellino, M., Clementi, M., Clerici, M., Moroni, M. and Galli, M. Homozygous delta32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11, 67-71 (1997).

47. Meyer, L., Magierowska, M., Hubert, J.-B., Rouzioux, C., Deveau, C., Sanson, F., Debre, P., Delfraissy, J.-F., Theodorou, I. and the SEROCO Study Group. Early protective effect of CCR-5 delta32 heterozygosity on HIV-1 disease progression: Relationship with viral load. AIDS 11, 73-78 (1997).

48. Sallusto, F., Mackay, C. R. and Lanzavecchia, A. Selective expression of of the Eotaxin receptor CCR-3 by human T helper 2 cells. Science 277, 2005-2007 (1997).

49. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C. R., Sodroski, J. and Gabuzda, D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385, 645-649 (1997).

50. Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O’Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K. and Hilgartner, M. W. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277, 959-965 (1997).

51. Wu, B. L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A. and Mackay, C. R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1 in vitro. J. Exp. Med. 185, 1681-1691 (1997).

52. Lapham, C.K., Ouyang, J., Chandrasekhar, B., Nguyen, N.Y., Dimitrov, D.S. and Golding, H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274, 602-605 (1996).

53. Hesselgesser, J., Halks-Miller, M., DelVecchio, V., Peiper, S. C., Hoxie, J., Kolson, D. L., Taub, D. and Horuk, R. CD4 independent interaction between HIV-1 gp120 and CXCR-4: Functional chemokine receptors are expressed in human neurons. Curr. Biol. 7, 112-121 (1997).

54. Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J. and Moore, J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384, 184-187 (1996).

55. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C. and Sodroski, J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183 (1996).

56. Hill, C. M., Deng, H., Unutmaz, D., Kewalramani, V.N., Bastiani, L., Gorny, M. K., Zolla-Pazner, S. and Littman, D. R. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor. J. Virol. 71, 6296-6304 (1997).

57. Clapham, P. R., McKnight, A. and Weiss, R. A. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4. J. Virol. 66, 3531-3537 (1992).

58. Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D., McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance, P. J., Wells, T. N. C., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau, N. R. and Hoxie, J. A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87, 745-756 (1996).

59. Reeves, J. D., McKnight, A., Potempa., S. Simmons, G., Gray, P. W., Power, C. A., Wells, T., Weiss, R. A. and Talbot, S. J. CD4 independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3 and V28 for entry. Virology 231, 130-134 (1997).

60. Atchison, R.E., Gosling, J., Monteclaro, F.S., Franci, C., Digilio, L., Charo, I.F. and Goldsmith, M.A. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines. Science 274, 1924-1926 (1996).

61. Bieniasz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S. G., Caron, M. G. and Cullen, B. R. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J. 16, 2599-2609 (1997).

62. Picard, L., Simmons, G., Power, C. A., Meyer, A., Weiss, R. A. and Clapham, P. R. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J. Virol. 71, 5003-5011 (1997).

63. Kuhmann, S. E., Platt, E. J., Kozak, S. L. and Kabat, D. Polymorphisms in the CCR5 genes of african green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J. Virol. 71, 8642-8656 (1997).

64. Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., Doms, R. W. and Parmentier, M. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87, 437-446 (1996).

65. Lu, Z.-H., Berson, J. F., Chen, Y.-H., Turner, J. D., Zhang, T.-Y., Sharron, M., Jenks, M. H., Wang, Z.-X., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C. and Doms, R. W. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94, 6426-6431 (1997).

66. Doranz, B. J., Lu, Z.-H., Rucker, J., Zhang, T.-Y., Sharron, M., Cen, Y.-H., Wang, Z.-X., Guo, H.-H., Du, J.-G., Accavitti, M. A., Doms, R. W. and Peiper, S. C. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71, 6305-6314 (1997).

67. Edinger, A. L., Amedee, A., Miller, K., Doranz, B. J., Endres, M., Sharron, M., Samson, M., Lu, Z.-H., Clements, J. E., Murphey-Corb, M., Peiper, S. C., Parmentier, M., Broder, C. C. and Doms, R. W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. USA 94, 4005-4010 (1997).

68. Ross, T., Bieniasz, P. D. and Cullen, B. R. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage tropic HIV-1. J Virol In Press.

69. Heesen, M., Berman, M. A., Benson, J. D., Gerard, C. and Dorf, M. E. Cloning of the mouse fusin gene, homologue to a human HIV-1 co-factor. J. Immunol. 157, 5455-5460 (1996).

70. Nagasawa, T., Nakajima, T., Tachibana, K., Iizasa, H., Bleul, C. C., Yoshie, O., Matsushima, K., Yoshida, N., Springer, T. A. and Kishimoto, T. Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA 93, 14726-14729 (1996).

71. Bieniasz, P. D., Fridell, R. A., Anthony, K. and Cullen, B. R. Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1. J. Virol. 71, 7097-7100 (1997).

72. Tachibana, K., Nakajima, T., Sato, A., Igarashi, K., Shida, H., Iizasa, H., Yoshida, N., Yoshie, O., Kishimoto, T. and Nagasawa, T. CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry. J. Exp. Med. 185, 1865-1870 (1997).

73. Pleskoff, O., N. Sol, B. Labrosse, and M. Alizon. Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (Fusin). J. Virol. 71 3259-3262 (1997).

74. Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. and Clapham, P. R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71, 6407-6415 (1997).

75. Ashorn, P. A., Berger, E A., and Moss, B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64, 2149-2156 (1990).

76. Kozak, S. L., Platt, E. J., Madani, N., Ferro, F. E., Jr., Peden, K. and Kabat, D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J. Virol. 71, 873-882 (1997).

77. Simmons, G., McKnight, A., Takeuchi, Y., Hoshino, H. and Clapham, P. R. Cell-to-cell fusion, but not virus entry in macrophages by T-cell line tropic HIV-1 strains: A V3 loop-determined restriction. Virology 209, 696-700 (1995).

78. Cheng-Mayer, C., Liu, R., Landau, N. R. and Stamatatos, L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J. Virol. 71, 1657-1661 (1997).

79. Brelot, A., Heveker, N., Pleskoff, O., Sol, N. and Alizon, M. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J. Virol. 71, 4744-4751 (1997).

80. Potempa, S., Picard, L., Reeves, J. D., Wilkinson, D., Weiss, R. A. and Talbot, S. J. CD4-independent infectin by human immunodeficiency virus type 2 strain ROD/B: The role of the N-terminal domain of CXCR-4 in fusion and entry. J. Virol. 71, 4419-4424 (1997).

81. Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B. and Goldsmith, M. A. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71, 7136-7139 (1997).

82. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein. Bron, R., Klasse, P. J., Wilkinson, D., Clapham, P. R., Pelchen-Matthews, A., Power, C., Wells, T. N. C., Kim, J., Peiper, S. C., Hoxie, J. A. and Marsh, M. J. Virol. 71, 8405-8415 (1997).

83. Arenzanaseisdos, F., Virelizier, J. L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B. and Baggiolini, M. HIV blocked by a chemokine antagonist. Nature 383, 400 (1996).

84. Simmons, G., Clapham, P.R., Picard, L., Offord, R.E., Rosenkilde, M. M., Schwartz, T.W., Buser, R., Wells, T. N. C. and Proudfoot, W. E. I. Potent inhibition of HIV infectivity in macrophages and lymphocytes by a novel CCR-5 antagonist. Science 276, 276-279 (1997).

85. Kledal, T. N., Rosenkilde, M. M., Coulin, f., Simmons, G., Johnsen, A. H., Alouani, S., Power, C. A., Lutichau, H. R., Gerstoft, J., Clapham, P. R., Clark-lewis, I., Wells, T. N. C. and Schwartz, T. W. A broad spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated hepesvirus. Science 277, 1656-1659 (1997).

86. Boschoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L., Siani, M. A., Sasaki, T., Williams, T. J., Gray, P. W., Moore, P. S., Chang, Y. And Weiss, R. A. Angiogenic and HIV-inhibitory functions of KSHV encoded chemokines. Science 278, 290-294 (1997).

87. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H. and Kishimoto, T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638 (1996).

88. Schols, D., Struyf, S., Van Damme, J. Esté, J.A., Henson, G. and De Clercq. E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388 (1997).

89. Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N. and Nagasawa,. T. A small molecule CXCR4 inhibitor that blocks T cell- line tropic HIV-1 infection. J. Exp. Med. 186, 1389-1393 (1997).

90. Doranz, B.J., Grovit-Ferbasi, K., Sharron, M.P., Mao, S.H., Goetz, M.B., Daar, E.S., Doms, R.W., and O'Brien, W. A. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395-1400 (1997).

91. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. and Landau, N. R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185, 621-628 (1997).

92. Moore, J. P. and Nara, P. L. The role of the V3 loop of gp120 in HIV infection. AIDS 5 Suppl 2, S21-S33 (1991).

93. Connor, R.I., Mohri, H., Cao, Y. and Ho, D.D. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol, 67, 1772-1777 (1993)

94. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A. and Mackay, C. R. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930 (1997).

95. Malykh, A., Reitz, M. S., Louie, A., Hall, L. and Lori, F., Multiple determiants for growth of human immunodeficiency virus in monocyte-macrophages. Virology 206, 646-650 (1994).

96. Reimann, K. A., Li, J. T., Voss, G., Lekutis, C., Tenner-Racz, K., Racz, P., Lin, W., Montefiori, D. C., Lee-Parritz, D. E., Lu, Y., Collman, R. G., Sodroski, J. and Letvin, N. L. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J. Virol. 70, 3198-3206 (1996).

97. McKnight, A., Weiss, R.A., Chotton, C., Takeuchi, Y., Hoshino, H. and Clapham, P.R. Change in tropism upon immune escape by human immunodeficiency virus. J. Virol. 69, 3167-3170 (1995).

98. Moore, J. P., Cao, Y. , Qing, L. , Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R. and Ho, D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol. 69, 101-109 (1995).

99. Moore, J., Jameson, B., Weiss, R. and Sattentau, Q. In Viral fusion mechanisms. Ed: J. Bentz Ed. CRC Press, Boca Raton, FL 233-289 (1993).

100. Ferguson, S. S. G., Zhang, J., Barak, L. S. and Caron, M. G. G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration. Biochem Soc. Trans. 24, 953-959 (1996).

101. Gosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C.-L., Goldsmith, M. A. and Charo, I. F. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transd uction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066 (1997).

102. Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J. and Gerard, C. HIV-1 entry and macrophage inflammatory protein-1 beta-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272, 6854-6857 (1997).

103. Aramori, I., Zhang, J., Ferguson, S. S. G., Bieniasz, P. D., Cullen, B. R. and Caron, M. G. Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signalling and internalization are dissociable from its role as an HIV-1 coreceptor. EMBO J. 16, 4606-4616 (1997).